WebDisclosure WebDisclosure
Basculer en Français
9551 Companies
188523 Keywords
120343 Articles
100658 Press releases
Headlines Articles Press releases Custom Health Inc. Remove
  1. Home
  2. Companies
  3. Custom Health Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/24/2024 at 13:40, 1 year 4 months ago

    Custom Health Launches Opioid Addiction Deterrence Task Force

    Medical Technology Task Force Opioid Crisis Policy Advocacy Prevention Strategies
  • BRIEF

    published on 07/24/2024 at 13:40, 1 year 4 months ago

    Custom Health lance un groupe de travail sur la dissuasion de la dépendance aux opioïdes

    Technologie Médicale Plaidoyer Politique Crise Des Opioïdes Force D'intervention Stratégies De Prévention
  • PRESS RELEASE

    published on 07/24/2024 at 13:35, 1 year 4 months ago

    Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition

    Custom Health Inc. announces the launch of the Opioid Addiction Deterrence Task Force by the American Medical Technology Coalition, focusing on innovative medical technologies to combat the opioid crisis
    Innovation Medical Technology Task Force Custom Health Inc. Opioid Addiction
    Logo of Custom Health Inc.
Accesswire
  • Published on 12/19/2025 at 01:00, 9 minutes ago

    Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited

  • Published on 12/19/2025 at 00:50, 19 minutes ago

    High Resolution Gravity Survey Targets Challenger Repeats

  • Published on 12/19/2025 at 00:00, 1 hour 9 minutes ago

    LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

  • Published on 12/18/2025 at 23:10, 1 hour 59 minutes ago

    Air T, Inc. Announces Closing of Regional Express Acquisition

  • Published on 12/18/2025 at 23:05, 2 hours 4 minutes ago

    BlackBerry Reports Third Quarter Fiscal Year 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 22:05, 3 hours 4 minutes ago

    Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology

  • Published on 12/18/2025 at 22:05, 3 hours 4 minutes ago

    Abivax to be Added to Nasdaq Biotechnology Index

  • Published on 12/18/2025 at 20:09, 5 hours ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 19:30, 5 hours 39 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT

  • Published on 12/18/2025 at 19:30, 5 hours 39 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 6 hours 39 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 18:30, 6 hours 39 minutes ago

    Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde

  • Published on 12/18/2025 at 17:45, 7 hours 24 minutes ago

    Cie du Bois Sauvage: Vernietiging eigen aandelen

  • Published on 12/18/2025 at 17:45, 7 hours 24 minutes ago

    Damartex réaffirme son éligibilité au PEA-PME

  • Published on 12/18/2025 at 17:45, 7 hours 24 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy